News room - Egetis Therapeutics

20 December, 2016 Overall survival data indicates that PledOx® does not negatively interfere with the anticancer effect of chemotherapy News English IR Optional

2 December, 2016 Final result of PledPharma’s rights issue News English IR Optional

11 November, 2016 Announcement of prospectus regarding PledPharma’s rights issue News English IR Optional

31 October, 2016 Nominations Committee for the 2017 AGM in PledPharma AB News English IR Optional

20 October, 2016 PledPharma announces a guaranteed rights issue of SEK 406 million in order to take PledOx® into phase lll News English IR Optional

20 October, 2016 Interim report January - September 2016 News English Report Interim IR Optional

20 October, 2016 Interim report January - September 2016 News English Report Interim Q3 IR Optional

25 August, 2016 Interim report January - June 2016 News English Report Interim IR Optional

25 August, 2016 Interim report January - June 2016 News Corporate Information Other Corporate Information English IR Optional

7 June, 2016 PledPharma reports constructive meeting with the European Medicines Agency (EMA) News English IR Optional

19 May, 2016 PledPharma to present the Phase IIb PLIANT study data at ASCO 2016 News English IR Optional

16 May, 2016 New data strengthens claim that PledOx® does not negatively interfere with the anti-cancer effect of chemotherapy News English IR Optional

29 April, 2016 Interim report first quarter 2016 News English Report Interim Q1 IR Optional

14 April, 2016 Presentation from the AGM is now available on the company's website News English IR Optional

29 February, 2016 Year end report 2015 News English Report Interim Yearend IR Optional

Press releases